This is being blown way out of proportion. Its clear the FDA is investigating their marketing practices and claims they are making on their drug out there in patient land. Its their job regarding how sales markets to doctors and even how it is advertised in whatever form. Its in the CFR that they do this! This happens all the time with big pharma and could result in the FDA simply warning to do this or not do that or to change that?
Its also clear litigation firms will jump on this like the article published early this morning. This ia market that has glommed onto the combi of the insurance thing coupled with the marketing thing to totally over-react regarding both when neither is resolved, clear, or impact-determined even mid term yet.
Its become a real risky bet to hold and/or buy QCOR until the track is more clear. It could go either way IMO, but likely more down today.
We will see? I hold some off this drop, but not going overboard. I doubt anybody is going to jail, over this but this is clearly a hyped situation and only time will tell how likely OVERHYPED it is!
If QCOR managment has been dumping heavy shares into this, that may cause them some problems over timing of that to all this news. Likely what the law firm is looking into!